Follow our financial story as we change the future of medicine.
On this page you can find financial reports, news and other information on CELLINK. Subscribe to our page to get all the latest updates.
Latest press releasesMore
September 3, 2019CELLINK announces a new product designed to be the most flexible six-printhead bioprinting platform on the market.
August 26, 2019RegulatoryCommunique from the Extraordinary General Meeting of CELLINK AB (publ)
August 8, 2019RegulatoryNotice of Extraordinary General Meeting of CELLINK AB (publ)
August 5, 2019RegulatoryCELLINK has entered an agreement to acquire single-cell dispensing company cytena GmbH.
July 11, 2019RegulatoryCELLINK has been granted a patent for "Clean chamber technology for 3D Printers and Bioprinters" from the Korean Intellectual Property Office
July 11, 2019Regulatory143% profitable growth and a successful integration of acquired technology
June 18, 2019RegulatoryCELLINK has completed a directed share issue of SEK 148.5 million
June 18, 2019RegulatoryCELLINK announces intention to carry out a directed share issue of approximately 500,000 shares of series B to finance a potential acquisition
May 2, 2019CELLINK launches new tissue model kits
April 24, 2019CELLINK BIO X wins the Grand Award of Design.
April 10, 2019RegulatoryCELLINK report continued growth and improved margins in the second quarter (December 2018-February 2019)
March 22, 2019CELLINK and the Adult Stem Cell Research Center at Seoul National University announce new agreement for bioprinting research
February 19, 2019RegulatoryCELLINK has been granted a patent for "3D printer and a method for 3D printing of a construct" from the Swedish Patent office
February 4, 2019CELLINK launches new product to bring fast and sharp live-cell imaging to every incubator
January 22, 2019RegulatoryInterim financial report 1, September – November 2018: Continued growth and improved margins
December 14, 2018RegulatoryCommunication from the Annual General Meeting on December 13, 2018
December 7, 2018RegulatoryHandelsbanken Fonder and AP4 buy shares in CELLINK from the founders
December 5, 2018CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing
December 4, 2018RegulatoryCELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery
November 30, 2018RegulatoryCELLINK has entered into an agreement to acquire the Biodispensing company Dispendix GmbH
November 14, 2018RegulatoryCELLINK publishes annual report for 2017/2018
November 6, 2018CELLINK IS LAUNCHING NEW BIOINKS
October 24, 2018RegulatoryInterim financial report 4 for the period 1st of June – 31st of August and the report for the full fiscal year
October 17, 2018CELLINK IS LAUNCHING NEW BIOINKS
September 11, 2018CELLINK brings on world distinguished scientist Dr. Mina J. Bisell to advisory board
September 4, 2018CELLINK’s bioink and bioprinters are being used in several progressive research areas
August 27, 2018CELLINK launches new bioink series based on laminins
July 16, 2018RegulatoryCELLINK to receive €2.5 million grant from EU for the development and commercializing project “TumorPrint “
July 11, 2018RegulatoryQuarterly report 3 for the period 1st of March – 31st of May and for the first 9 months
June 4, 2018RegulatoryCELLINK has completed a directed share issue of approximately SEK 100 million
June 4, 2018RegulatoryCELLINK intends to make a directed share issue of Class B shares
May 11, 2018RegulatoryCELLINK receives 3.5 MSEK order from distributor
April 13, 2018CELLINK lanserar 7 nya Biobläck, 3 nya kits med GelMA samt möjliggör 3D-Bioprinting av mångfasetterade vaskulära nätverk
January 17, 2018RegulatoryQuarterly report 1 for the period 1st of September – 30th of November
October 19, 2017RegulatoryEnd of the year report for the period 1 of September – 31st of August and Quarterly report 4
Calendar More
January 22, 2019Interim report September – November 2018
April 10, 2019Interim report December – February 2019
July 11, 2019Interim report March – May 2019
October 24, 2019Year-end report September - August (Q1-Q4) 2018/2019